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Abstract
Purpose The aim was to evaluate the utility of ultraso-
nographic examinations, such as the Doppler technique, in
diagnosing women with postmenopausal bleeding.
Methods Speciﬁcally, maximum end-diastolic velocity of
blood ﬂow (MEDV), time-averaged maximum velocity of
blood ﬂow (TAMXV) and peak systolic velocity of blood
ﬂow (PSV) were evaluated. Data were obtained and ana-
lyzed from a group of 100 female patients diagnosed and
treated because of abnormal bleeding from the genitals in
the Gynecological-Obstetrics Clinical Hospital of Poznan
University of Medical Sciences. The following packages
were used for statistic analyses: STATISTICA v 7.1
(StatSoft, Inc. 2005), StatXACT v.5.0.3, CYTEL SOFT-
WARE CORPORATION and Analyse-it Software v.1.68.
Results The parameters evaluated were highest in the
carcinoma group, lower when proliferation was diagnosed
and the lowest in the control group.
Conclusions Transvaginal ultrasonography diagnostics
using the Doppler technique was found to play an impor-
tant role in the diagnostic process of pathologies within the
endometrium.
Keywords Endometrial carcinoma  MEDV 
Proliferation of the endometrium  PSV  TAMXV
Introduction
The introduction of ultrasonography to gynecological
diagnostics has improved the precision with which the
endometrium can be evaluated in physiological and path-
ological states. Although carcinoma of the endometrium
does not show typical ultrasonographic features, ultraso-
nographic examination with a transvaginal probe is typi-
cally used to detect these neoplasms. This examination is
also very useful in evaluating the degree of inﬁltration
before an operation. Ultrasonography is non-invasive and
is currently one of the most frequently used diagnostic
techniques for evaluating the endometrium. Thus, ultraso-
nography has become an important supplement to a routine
gynecological examination, and clinical procedures are
often based on the results of this examination. However,
using this technique to measure the thickness of the
endometrium itself is not sufﬁcient [1–4].
Imaging using ultrasonography with the color Doppler
technique created the potential to distinguish malignant
changes from non-malignant changes. This is one of the
most advanced diagnostic methods used in the diagnostic
process of female genitals. Analyses of blood ﬂow-
velocity in artery vessels based on maximum blood ﬂow-
velocities makes it possible to create objective Doppler
measurements, which allows for comparisons using any
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DOI 10.1007/s00404-010-1824-3apparatus. However, due to existing controversies related
to the measurement of particular Doppler parameters, the
aim of this paper was to analyze the perfusion in uterine
arteries in women hospitalized due to abnormal bleeding
from the uterus using vaginal ultrasonography with color
Doppler.
Materials and methods
A group of 100 female patients diagnosed with and treated
for abnormal bleeding from the uterus in the Clinic of
Gynecological Surgery of the Gynecological-Obstetrics
Clinical Hospital of Poznan University of Medical Sci-
ences between December 2005 and January 2007, were
studied. The median age of endometrial cancer patients
was 62 years, of patients with endometrial hyperplasia was
59 years and 46 years for the women without endometrial
pathology.
Gynecological examination and ultrasounds were
always done by the same doctor. During ultrasound
examination with empty bladder of patients we used vag-
inal probe 5.0–6.5 Hz of Aloka model 5500. After analysis
in the gray scale we always performed Doppler examina-
tion analysis.
Based on the analysis of blood velocity wave form in
artery vessels, the following parameters were evaluated:
time-averaged maximum velocity of blood ﬂow (TAM-
XV), maximum end-diastolic velocity of blood ﬂow
(MEDV) and peak systolic velocity of blood ﬂow (PSV).
These values were calculated automatically using ultraso-
nographic software. Average values of three measurements
of consecutive blood velocity waves were assumed to be
representative for the examination conducted. Results of
this ultrasonography examination were compared with a
histopathological examination of the endometrium. To
evaluate the endometrium, the diagnostic curettage was
done and in some cases the endometrium was collected
after hysterectomy. Patients were divided into following
groups: 43 patients in whom endometrial carcinoma was
diagnosed during further diagnostics; 11 women in whom
hyperplastic changes of endometrium were detected during
further diagnostics and 46 patients in whom no changes
were diagnosed in the endometrium, as a control group.
Histopathological examination was performed in histopa-
thological laboratory in our hospital.
Curettage was always performed in general anesthesia,
after dilatation of cervical canal. We collected material
from the cervix and from the uterine cavity in different
glasses and after the procedure the material was sent
immediately to the histopathological laboratory. Hyster-
ectomies were always performed transabdominaly in the
general anesthesia.
The results obtained were submitted to a statistical
analysis. TAMXV, MEDV and PSV values, measured on
an interval scale due to the diagonal distribution of the
parameters analyzed, were characterized with the aid of
median values. The distributions of the above-mentioned
parameters were assessed to determine their normality
using a Shapiro–Wilk test. An analysis of variance
ANOVA with a Newman–Keuls post-hoc test and a non-
parametric Kruskal–Wallis test with Dunn’s multiple
comparisons test were used in order to make comparisons
between the three groups. A level of 0.05 was assumed for
the risk of erroneous conclusions and for the signiﬁcance
level in this paper.
Calculations were performed using the STATISTICA v
7.1 (StatSoft, Inc. 2005) statistical package, as well as
StatXACT v.5.0.3 by CYTEL SOFTWARE CORPORA-
TION and Analyse-it Software v.1.68.
The studies have been approved by The Ethics Com-
mittee in the University of Medical Sciences in Poznan on
8 December 2005 and the project number is 1681/05.
Results
After histopathological examination we observed three
groups of patients: 43 patients with endometrial carcinoma,
11 women with hyperplastic changes of the endometrium
and 46 patients with no pathological changes in the endo-
metrium, as a control group.
After statistical analysis it was shown that endometrial
hyperplasia and carcinoma are found most frequently in
urban women aged 51–60 years old. Among patients living
in the country these lesions were observed much less fre-
quently. Before the age of 40 endometrial carcinoma was
found occasionally. It turned out that among factors coin-
ciding with these endometrial pathologies the biggest
importance was found for obesity, arterial hypertension and
diabetes. Endometrial hyperplasia was most frequently
accompanied by cholecystolithiasis, while the risk of
endometrial carcinomas was much less affected by this
disease. Menopause after the age of 51 years increased the
risk of development of carcinoma or hyperplasia. However,
early menarche was not recorded in these groups. Increased
parity was not a protective factor against the disease.
Relationships occurring between the three groups of
patients and the TAMXV are shown in Table 1.
The highest median value of TAMXV, 18.50 cm/s, was
observed in the group with carcinoma of the endometrium.
The median value of TAMXV was lower in the group of
proliferations (TAMXV = 17.00 cm/s) and the lowest in
the control group (16.40 cm/s).
When comparing average values of TAMXV in the
different groups, higher values were observed in patients
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123with carcinoma (TAMXV = 20.19 cm/s) and with prolif-
eration of the endometrium (TAMXV = 18.49 cm/s) than
in women with no pathology within the endometrium
(TAMXV = 17.20 cm/s). However, these differences were
not statistically signiﬁcant. MEDV values based on mea-
surements in uterine arteries are shown in Table 2.
The median value of MEDV was 10.00 cm/s in patients
with carcinoma, 8.90 cm/s in patients with proliferation
and 7.95 cm/s in the control group. Average MEDV values
were lowest in the group with carcinoma of the endome-
trium, amounting to 10.60 cm/s. Similar results were
obtained in the group of proliferations (MEDV = 8.58 cm/s)
and in the control group (MEDV = 8.99 cm/s). However,
no signiﬁcant differences of MEDV were found in the
statistical analyses performed.
In the carcinoma and proliferation groups, similar
median values of PSV, 34.10 and 34.20 cm/s, were
obtained. A lower median value, 29.55 cm/s, was obtained
in the control group. Comparisons of average values of
maximum systolic velocity of blood ﬂow did not show any
statistically signiﬁcant differences between the three
groups, despite the fact that the PSV values obtained were
highest in women with carcinoma, lower in patients with
proliferation and much lower in the control group
(Table 3).
To summarize the results of the analysis, the highest
values of TAMXV, MEDV and PSV were observed in the
carcinoma group, while values of these parameters were
lower in the proliferation group and lowest in the control
group. However, it is important to highlight that no
parameter measured was signiﬁcantly higher in the group
of patients with carcinoma or proliferation in comparison
with the control group.
Discussion
In recent years, many studies have focused on the use of
the Doppler technique in evaluating blood ﬂow in artery
vessels. Many authors have reported that these examina-
tions are important in enabling non-malignant and malig-
nant changes to be distinguished. In the results of the
present study, no statistically signiﬁcant increase of max-
imum blood ﬂow velocity in uterine arteries was observed
in patients with carcinoma or proliferation in comparison to
the group showing no pathology within the endometrium.
Our results are compatible with the results obtained by
Sladkevicius et al. [5]. This study found no statistically
signiﬁcant differences between TAMXV values in groups
of women studied in an analysis of blood perfusion in
uterine arteries.
The same authors, Sladkevicius et al. [6] in another
study say that the measurement of endometrial thickness
with transvaginal ultrasonography is a better method for
discriminating pathologies within endometrium than that
Doppler velocimetry of the uterine arteries. Szpurek et al.
[7] presented a different opinion. While evaluating TAM-
XV values in uterine arteries in 58 patients with endome-
trial carcinoma, they showed signiﬁcantly higher values of
this parameter in comparison with TAMXV values in 75
women with no changes detected in the histopathological
analysis of the endometrium.
Table 1 Comparison of TAMXV (cm/s) values in the cancer and proliferation groups and in the control group
Number
of patients
Average Minimum Maximum Median 25 percentile 75 percentile
Carcinoma 43 20.19070 10.20000 36.90000 18.50000 14.70000 24.60000
Proliferation 11 18.49091 12.60000 28.50000 17.00000 15.30000 22.40000
Control group 46 17.20000 9.60000 28.60000 16.40000 13.70000 21.10000
Total 100 18.62800 9.60000 36.90000 17.20000 14.20000 22.40000
P value [0.05 [0.05 [0.05 [0.05 [0.05 [0.05
Table 2 Comparison of MEDV (cm/s) values in the cancer and proliferation groups and in the control group
Number
of patients
Average Minimum Maximum Median 25 percentile 75 percentile
Carcinoma 43 10.60930 2.800000 23.500000 10.00000 7.600000 12.10000
Proliferation 11 8.58182 4.800000 11.300000 8.900000 7.600000 9.00000
Control group 46 8.99783 2.400000 21.100000 7.950000 6.500000 11.40000
Total 100 9.64500 2.400000 23.500000 8.900000 6.900000 11.80000
P value [0.05 [0.05 [0.05 [0.05 [0.05 [0.05
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123In data published in 2005, Englert-Golon et al. [8] also
demonstrated the utility of TAMXV in evaluating uterine
arteries in women with abnormal postmenopausal bleeding.
After analyzing the results of 256 patients, these authors
obtained signiﬁcantly higher values of this parameter in the
group of endometrial carcinoma in comparison with the
group of proliferations of the endometrium.
In the databases available online, there are few infor-
mation related to the evaluation of the maximum velocity
of blood ﬂow in the uterine arteries. However, after anal-
ysis of available data, it can be noted that the authors have
reported an increase in the value of these parameters in
patients with pathology in the endometrium but such dif-
ferences were not always statistically signiﬁcant.
Conclusions
1. Transvaginal ultrasonography diagnostics using the
Doppler technique is a useful method for diagnosing
pathologies within the endometrium.
2. Evaluating blood ﬂow velocity in uterine arteries in
women with abnormal bleeding from the genitals does
not allow groups with a higher risk of proliferation or
carcinoma of the endometrium to be distinguished.
Conﬂict of interest The authors declare that they have no conﬂict
of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Epstein E, Skoog L, Isberg PE et al (2002) An algorithm including
results of gray-scale and power Doppler ultrasound examination to
predict endometrial malignancy in women with postmenopausal
bleeding. Ultrasound Obstet Gynecol 4(20):370–376
2. Lynch PM (1999) Clinical challenges in management of familial
adenomatous polyposis and hereditary non polyposis colorectal
cancer. Cancer 86(11):25–33
3. Stachowicz N, Czekierdowski A, Daniłos ´ J, Kotarski J (2002) Use
of three-dimensional ultrasonography in the evaluation of the
volume of the endometrium in women experiencing bleeding from
the uterine cavity. Ginekol Pol 11(73):970–975
4. Warming L, Ran P, Skouby S, Christiansen C (2002) Measurement
precision and normal range of endometrial thickness in a
postmenopausal population by transvaginal ultrasounds. Ultra-
sound Obstet Gynecol 5(20):492–495
5. Sladkevicius P, Valentin L, Marsal K (1995) Transvaginal gray-
scale and Doppler ultrasound examinations of the uterus and
ovaries in healthy postmenopausal women. Ultrasound Obstet
Gynecol 6(2):81–90
6. Sladkevicius P, Valentin L, Marsal K (1994) Endometrial thick-
ness and Doppler velocimetry of the uterine arteries as discrim-
inators of endometrial status in women with postmenopausal
bleeding: a comparative study. Am J Obstet Gynecol 171(3):722–
728
7. Szpurek D, Moszyn ´ski R, Sajdak S, Roszak A (2000) Evaluation
of blood ﬂow in the arteries of the uterus in patients with
endometrial carcinoma by means of vaginal ultrasonography using
the color Doppler technique. Nowotwory 50(1):35–38
8. Englert-Golon M, Szpurek D, Moszyn ´ski R, Pawlak M, Sajdak S
(2005) Diagnostic value of evaluating blood ﬂow by means of the
‘‘power’’ angio Doppler technique in uterine arteries and in
endometrium vessels in women with postmenopausal bleeding.
Ginek Pol 76(Suppl 2):134
Table 3 Comparison of PSV (cm/s) values in the cancer and proliferation groups and in the control group
Number
of patients
Average Minimum Maximum Median 25 percentile 75 percentile
Carcinoma 43 34.11860 16.60000 55.30000 34.10000 26.30000 39.80000
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